MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
AKTS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Aktis Oncology (AKTS) Ownership - Who owns Aktis Oncology?

Aktis Oncology Inc is a clinical-stage oncology company focused on expanding the breakthrough potential of targeted radiopharmaceuticals to large patient populations, including those not addressed by existing platform technologies... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Telecommunications Equipment
Address
9805 Northcross Center Court
Phone
+1 704 997-5735
Employees
222
Web
https://www.akoustis.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
1.13B
P/E Ratio
N/A
Total Cash
N/A
Projected Growth
N/A
Total Debt
N/A
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
N/A
Total Debt/Equity
N/A
Revenue/Share
0.12 USD as % of share price
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
View AI-Driven Trading for AKTS
A.I. Advisor
published General Information

General Information

a manufacturer of filter products for radio frequency front-ends for mobile wireless devices

Industry Biotechnology

Profile
Details
Industry
Telecommunications Equipment
Address
9805 Northcross Center Court
Phone
+1 704 997-5735
Employees
222
Web
https://www.akoustis.com